Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Locally Advanced Pancreatic Cancer × zimberelimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Recurrence 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced Pancreatic Cancer 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Neuroendocrine 1

Interventions

zimberelimab 1 surufatinib 1 Radiosurgery 1 Immunotherapy 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Peking University Third Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡